Literature DB >> 2409872

Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia.

A W Nienhuis, T J Ley, R K Humphries, N S Young, G Dover.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2409872     DOI： 10.1111/j.1749-6632.1985.tb17189.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

Review 1.  Future prospects for treatment of hemoglobinopathies.

Authors:  J A Stamatoyannopoulos
Journal:  West J Med       Date:  1992-12

2.  Emodin can induce K562 cells to erythroid differentiation and improve the expression of globin genes.

Authors:  Yan-Ni Ma; Ming-Tai Chen; Zhi-Kui Wu; Hua-Lu Zhao; Hai-Chuan Yu; Jia Yu; Jun-Wu Zhang
Journal:  Mol Cell Biochem       Date:  2013-06-07       Impact factor: 3.396

3.  Azapyrimidine analogues: inhibition of viral DNA synthesis and protein synthesis in SV40 infected BSC-1 cells.

Authors:  M Johnson-Thompson; D Albury
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

4.  MBD2 contributes to developmental silencing of the human ε-globin gene.

Authors:  Jeremy W Rupon; Shou Zhen Wang; Merlin Gnanapragasam; Stefanos Labropoulos; Gordon D Ginder
Journal:  Blood Cells Mol Dis       Date:  2011-02-04       Impact factor: 3.039

5.  Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells.

Authors:  Sylvia T Singer; Elliott P Vichinsky; Sandra Larkin; Nancy Olivieri; Nancy Sweeters; Frans A Kuypers
Journal:  Am J Hematol       Date:  2008-11       Impact factor: 10.047

6.  Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease.

Authors:  Hassana Fathallah; Ali Taher; Ali Bazarbachi; George F Atweh
Journal:  Blood Cells Mol Dis       Date:  2009-04-05       Impact factor: 3.039

7.  Mechanism of Hb F stimulation by S-stage compounds. In vitro studies with bone marrow cells exposed to 5-azacytidine, Ara-C, or hydroxyurea.

Authors:  R Galanello; G Stamatoyannopoulos; T Papayannopoulou
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

8.  In vitro and in vivo induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor.

Authors:  Aidan G Gilmartin; Arthur Groy; Elizabeth R Gore; Charity Atkins; Edward R Long; Monica N Montoute; Zining Wu; Wendy Halsey; Dean E McNulty; Daniela Ennulat; Lourdes Rueda; Melissa Pappalardi; Ryan G Kruger; Michael T McCabe; Ali Raoof; Roger Butlin; Alexandra Stowell; Mark Cockerill; Ian Waddell; Donald Ogilvie; Juan Luengo; Allan Jordan; Andrew B Benowitz
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

Review 9.  Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia-Current Status and Perspectives in Fetal Hemoglobin Reactivation.

Authors:  Noel Yat Hey Ng; Chun Hay Ko
Journal:  Int Sch Res Notices       Date:  2014-10-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.